The Anesthetic Gas Evaporator segmentation by application delineates three primary end‑uses that collectively shape market dynamics. Surgical anesthesia dominates with an estimated 70 % share, reflecting its pervasive adoption across hospital operating rooms, ambulatory surgical centers, and specialty clinics; this segment drives the bulk of capital expenditure on high‑throughput evaporators due to stringent sterility and reliability standards. Veterinary anesthesia accounts for roughly 20 % of the market, where evaporators are tailored to smaller animal patients and field‑mobile units, influencing demand for compact, rugged designs and moderate throughput capacities. The remaining 10 % originates from research and development laboratories, which require highly precise, low‑volume evaporators for experimental protocols and drug discovery, thereby supporting niche manufacturers offering customizable control interfaces. Collectively, these application categories define the overall market size, with each segment’s proportional weight directly linked to its operational volume, regulatory environment, and equipment turnover rates.